Compare SKYT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYT | AMPH |
|---|---|---|
| Founded | 1991 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2005 |
| Metric | SKYT | AMPH |
|---|---|---|
| Price | $30.28 | $21.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $26.50 | ★ $28.38 |
| AVG Volume (30 Days) | ★ 1.1M | 408.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1842.86 | N/A |
| EPS | ★ 2.44 | 2.03 |
| Revenue | $442,139,000.00 | ★ $719,887,000.00 |
| Revenue This Year | $40.16 | $6.90 |
| Revenue Next Year | $4.52 | $4.64 |
| P/E Ratio | $12.74 | ★ $10.76 |
| Revenue Growth | ★ 29.18 | N/A |
| 52 Week Low | $6.99 | $17.03 |
| 52 Week High | $36.07 | $31.26 |
| Indicator | SKYT | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 52.62 |
| Support Level | $29.80 | $20.39 |
| Resistance Level | $31.19 | $23.08 |
| Average True Range (ATR) | 1.18 | 0.78 |
| MACD | -0.14 | 0.09 |
| Stochastic Oscillator | 34.42 | 45.83 |
SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.